{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:05:13Z","timestamp":1790017513568,"version":"4.0.1"},"reference-count":45,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"Young Elite Scientists Sponsorship Program by CAST","award":["2023QNRC001"],"award-info":[{"award-number":["2023QNRC001"]}]},{"name":"the National High Level Hospital Clinical Research Funding","award":["2024IR33"],"award-info":[{"award-number":["2024IR33"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2025YC02"],"award-info":[{"award-number":["2025YC02"]}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232180"],"award-info":[{"award-number":["7232180"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Prediabetes is highly prevalent and biologically heterogeneous, yet current glycemic definitions do not adequately capture differences in cardiometabolic and kidney risk. We aimed to identify metabolically defined subtypes of prediabetes using circulating metabolites and to examine their associations with cardiovascular-kidney-metabolic outcomes. We analyzed 24,638 participants with prediabetes from the UK Biobank who had metabolomics data available. Metabolomic biomarkers related to type 2 diabetes, cardiovascular disease, and chronic kidney disease were identified using machine learning\u2013based feature selection methods, and unsupervised clustering was applied to derive metabolic subtypes. Associations between subtypes and cardiometabolic outcomes were evaluated, and interactions between dietary patterns and metabolic subtypes were explored. Mendelian randomization analyses were conducted to investigate potential causal roles of key metabolomic biomarkers. Three metabolically distinct subtypes of prediabetes were identified, representing low-, intermediate-, and high-risk metabolic profiles. These subtypes showed progressively higher risks of developing type 2 diabetes, cardiovascular disease, and chronic kidney disease during follow-up, and the associations between diet quality and disease outcomes differed across subtypes. Several metabolomic biomarkers demonstrated potential causal links with cardiometabolic outcomes. These findings highlight the metabolic heterogeneity of prediabetes and suggest that metabolomics-based subtypes may improve risk stratification and support precision prevention strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>Previous studies have identified heterogeneity among prediabetes subgroups using clinical characteristics; however, biological and metabolic heterogeneity remains insufficiently captured. This study examined whether data-driven clustering based on metabolomic biomarkers could define distinct prediabetes subtypes with differential type 2 diabetes, cardiovascular disease, and chronic kidney disease risk. Using 16 metabolomic biomarkers, we identify three metabolically distinct clusters showing progressively higher risks of incident type 2 diabetes, cardiovascular disease, and chronic kidney disease. Differential diet-cluster associations across clusters were obtained, and Mendelian randomization supported potential causal roles for several metabolomic biomarkers. Metabolomics-based stratification may improve risk prevention and enable cluster-specific dietary interventions in prediabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db26-0218","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:18:16Z","timestamp":1786378696000},"page":"1934-1945","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomics-Defined Subtypes of Prediabetes and Risk of Cardiovascular-Kidney-Metabolic Outcomes"],"prefix":"10.2337","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1244-2194","authenticated-orcid":false,"given":"Fei","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital 1 , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2925-3859","authenticated-orcid":false,"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital 1 , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine 2 , Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital 1 , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital 1 , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital 1 , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcui","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital 1 , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuxiang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital 1 , Beijing, China"},{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University 3 , Beijing, China"},{"name":"Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education 4 , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3718-243X","authenticated-orcid":false,"given":"Feifei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Digital Health and Artificial Intelligence, Peking University First Hospital 5 , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-9483","authenticated-orcid":false,"given":"Ying","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Peking University First Hospital 1 , Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"2026092114514372700_B1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41572-025-00635-0","article-title":"Prediabetes","volume":"11","author":"Unnikrishnan","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"2026092114514372700_B2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/OGX.0000000000001177","article-title":"Diagnosis and management of prediabetes: a review","volume":"78","author":"Echouffo-Tcheugui","year":"2023","journal-title":"Obstet Gynecol Surv"},{"key":"2026092114514372700_B3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"2026092114514372700_B4","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2337\/dc22-2376","article-title":"Global prevalence of prediabetes","volume":"46","author":"Rooney","year":"2023","journal-title":"Diabetes Care"},{"key":"2026092114514372700_B5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.2337\/dc23-1514","article-title":"Natural history of type 2 diabetes in Indians: time to progression","volume":"47","author":"Narayan","year":"2024","journal-title":"Diabetes Care"},{"key":"2026092114514372700_B6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S2213-8587(23)00132-8","article-title":"Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial","volume":"11","author":"Zhang","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026092114514372700_B7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12933-022-01592-8","article-title":"Age-specific difference in the association between prediabetes and subclinical atherosclerosis: an analysis of a Chinese prospective cohort study","volume":"21","author":"Cao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2026092114514372700_B8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/eurjpc\/zwad106","article-title":"Predictive performance of established cardiovascular risk scores in the prediabetic population: external validation using the UK Biobank data set","volume":"30","author":"Li","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2026092114514372700_B9","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.kint.2025.06.019","article-title":"Iohexol clearance, but not estimated GFR, reveals a steeper GFR decline in patients with prediabetes","volume":"108","author":"Melsom","year":"2025","journal-title":"Kidney Int"},{"key":"2026092114514372700_B10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","article-title":"Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study","volume":"368","author":"Lindstr\u00f6m","year":"2006","journal-title":"Lancet"},{"key":"2026092114514372700_B11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00125-010-1948-9","article-title":"Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study","volume":"54","author":"Gong","year":"2011","journal-title":"Diabetologia"},{"key":"2026092114514372700_B12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications: the DPP Outcomes Study","volume":"3","author":"Nathan","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026092114514372700_B13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/dc10-1288","article-title":"Reduction in the incidence of type 2 diabetes with the Mediterranean diet","volume":"34","author":"Salas-Salvad\u00f3","year":"2011","journal-title":"Diabetes Care"},{"key":"2026092114514372700_B14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"2026092114514372700_B15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41598-020-80572-y","article-title":"Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohort from a Japanese general population","volume":"11","author":"Iwasaki","year":"2021","journal-title":"Sci Rep"},{"key":"2026092114514372700_B16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"2026092114514372700_B17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"2026092114514372700_B18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","article-title":"Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes","volume":"27","author":"Wagner","year":"2021","journal-title":"Nat Med"},{"key":"2026092114514372700_B19","doi-asserted-by":"crossref","first-page":"100958","DOI":"10.1016\/j.xcrm.2023.100958","article-title":"Data-driven subgroups of prediabetes and the associations with outcomes in Chinese adults","volume":"4","author":"Zheng","year":"2023","journal-title":"Cell Rep Med"},{"key":"2026092114514372700_B20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-publhealth-090419-102644","article-title":"Prediabetes and what it means: the epidemiological evidence","volume":"42","author":"Echouffo-Tcheugui","year":"2021","journal-title":"Annu Rev Public Health"},{"key":"2026092114514372700_B21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00125-020-05310-5","article-title":"Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes","volume":"64","author":"Ziegler","year":"2021","journal-title":"Diabetologia"},{"key":"2026092114514372700_B22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2337\/dc21-1705","article-title":"Metabolomics and type 2 diabetes risk: an updated systematic review and meta-analysis of prospective cohort studies","volume":"45","author":"Morze","year":"2022","journal-title":"Diabetes Care"},{"key":"2026092114514372700_B23","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/ATVBAHA.124.321282","article-title":"Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks","volume":"44","author":"Lee","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026092114514372700_B24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.ajkd.2024.03.028","article-title":"Associations of urine and plasma metabolites with kidney failure and death in a chronic kidney disease cohort","volume":"84","author":"Steinbrenner","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"2026092114514372700_B25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.ajkd.2023.11.013","article-title":"Metabolites associated with uremic symptoms in patients with CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"84","author":"Wulczyn","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"2026092114514372700_B26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41569-019-0206-1","article-title":"Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes","volume":"16","author":"Wu","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2026092114514372700_B27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"2026092114514372700_B28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"2026092114514372700_B29","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"2026092114514372700_B30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12933-023-01999-x","article-title":"Association between a Mediterranean lifestyle and type 2 diabetes incidence: a prospective UK Biobank study","volume":"22","author":"Maroto-Rodriguez","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2026092114514372700_B31","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2337\/dc23-2448","article-title":"Timing of moderate to vigorous physical activity, mortality, cardiovascular disease, and microvascular disease in adults with obesity","volume":"47","author":"Sabag","year":"2024","journal-title":"Diabetes Care"},{"key":"2026092114514372700_B32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12933-025-02581-3","article-title":"Improving 10-year cardiovascular risk prediction in patients with type 2 diabetes with metabolomics","volume":"24","author":"Xie","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"2026092114514372700_B33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12933-025-02899-y","article-title":"Unveiling biomarkers via plasma metabolome profiling for diabetic macrovascular and microvascular complications","volume":"24","author":"Li","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"2026092114514372700_B34","unstructured":"UK Biobank\n          . Category 220. Accessed 1 July 2026. Available from https:\/\/biobank.ndph.ox.ac.uk\/ukb\/label.cgi?id=220"},{"key":"2026092114514372700_B35","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00125-021-05485-5","article-title":"Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational study","volume":"64","author":"Lugner","year":"2021","journal-title":"Diabetologia"},{"key":"2026092114514372700_B36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.csda.2006.11.025","article-title":"Cluster-wise assessment of cluster stability","volume":"52","author":"Hennig","year":"2007","journal-title":"Comput Stat Data Anal"},{"key":"2026092114514372700_B37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"2026092114514372700_B38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(25)00285-2","article-title":"Trajectories of type 2 diabetes and cancer in 330\u2009000 individuals with prediabetes: 20-year observational study in England","volume":"14","author":"Zaccardi","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026092114514372700_B39","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/db09-1114","article-title":"Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women","volume":"59","author":"Mora","year":"2010","journal-title":"Diabetes"},{"key":"2026092114514372700_B40","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.2337\/dc21-0438","article-title":"Dietary intake of linoleic acid, its concentrations, and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective cohort studies","volume":"44","author":"Mousavi","year":"2021","journal-title":"Diabetes Care"},{"key":"2026092114514372700_B41","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41746-025-02075-2","article-title":"Metabolomic characterization of frailty identifies subtype-specific management strategies","volume":"8","author":"Xiao","year":"2025","journal-title":"NPJ Digit Med"},{"key":"2026092114514372700_B42","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1210\/clinem\/dgab075","article-title":"HDL particle subspecies and their association with incident type 2 diabetes: the PREVEND study","volume":"106","author":"Sokooti","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092114514372700_B43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2337\/dc19-0772","article-title":"High concentration of medium-sized HDL particles and enrichment in HDL paraoxonase 1 associate with protection from vascular complications in people with long-standing type 1 diabetes","volume":"43","author":"Vaisar","year":"2020","journal-title":"Diabetes Care"},{"key":"2026092114514372700_B44","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00125-019-05001-w","article-title":"Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts","volume":"62","author":"Ahola-Olli","year":"2019","journal-title":"Diabetologia"},{"key":"2026092114514372700_B45","doi-asserted-by":"crossref","first-page":"e029552","DOI":"10.1161\/JAHA.123.029552","article-title":"Lipoprotein characteristics and incident coronary heart disease: prospective cohort of nearly 90\u2009000 individuals in UK Biobank","volume":"12","author":"Jin","year":"2023","journal-title":"J Am Heart Assoc"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/10\/1934\/892014\/db260218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/10\/1934\/892014\/db260218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:51:53Z","timestamp":1790016713000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/75\/10\/1934\/172322\/Metabolomics-Defined-Subtypes-of-Prediabetes-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,8,10]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db26-0218","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}